FounderNest™

Company	Fit assessment	Description	Subspaces	HQ Location	Founded	Employees	Total Funding Raised	Funding Status	Received on
Picks for your space		51–60 of 60
Celula	Cellula focuses on women's health through its engagement in reproductive health and offers advanced genetic testing solutions.	Researcher and developer of advanced genetic testing technology in the field of reproductive health. The company's technology focuses on the clinical application of cutting edge technologies in areas such as flow cytometry, and supporting reagents, non-invasive prenatal testing (NIPT), and tumor companion diagnosis through liquid biopsies, providing testing methods for various diseases.	Genomic and Genetic Testing	Chengdu (China)	2013	51 - 200	$7.76M	Series B, $7.32M, September 1, 2020	1 year ago
Genetic Technologies	Genetic Technologies is dedicated to advancing women's health through personalized risk assessments and comprehensive genetic testing solutions.	Genetic Technologies is a biotechnology research company. They offer medical diagnostic and sequencing services include medical, forensic, paternity and animal genomic testing, enabling physicians and doctors to get correct data for treatment of the patients.	Genomic and Genetic Testing	Fitzroy (Australia)	1987	51 - 200	$13.10M	IPO, July 30, 1987	1 year ago
CognitiveCare	CognitiveCare is dedicated to advancing women's health through AI-driven risk detection and management solutions, particularly in maternal and infant health.	CognitiveCare is a trailblazing force in improving healthcare outcomes. We utilize scientific rigor to unveil and address health disparities, enhance disease prevention and management, accelerate health economics outcomes research, and catalyze optimal efficacy in pharma and life sciences. With a foundation rooted in patented and proprietary risk quantification and resource allocation algorithms, we serve payers, providers, policymakers, public health departments, pharma, and life sciences clients, driving impact for both individual and population health. CongitiveCare is poised to revolutionize the healthcare landscape through its algorithm hub, interdisciplinary approach, and real-world evidence expertise. The company's impactful strides in maternal and infant health, children's health, mental health, substance use disorder, eye health, infectious diseases, and pathology lay the foundation for accelerating our mission to build healthier communities.	Artificial Intelligence in Women's Health Care	Milpitas (United States)	2018	11 - 50	$300.00K	Seed, $300.00K, December 1, 2020	1 year ago
Prognica Labs	Prognica Labs is dedicated to advancing women's health through AI-driven technologies for early detection and diagnosis of breast cancer, including enhancements to mammography.	Prognica Labs is an AI based company working on early detection and diagnosis of breast cancer, with a strong mission to democratize early detection, diagnosis and treatment of Breast Cancer by making it more accurate, accessible & affordable. We have been at the forefront of bringing research, awareness, and economical and accessible screening solution to healthcare industry and the society.	Artificial Intelligence in Women's Health Care	Dubai (United Arab Emirates)	2019	1 - 10		Pre-Seed, July 16, 2019	1 year ago
Agnes Health	The company focuses on women's health and utilizes AI and telemedicine to improve health outcomes for women globally.	The Inclusive AI-Powered Health Ally for Women. On a mission to positively transform health indices for women, globally.	Artificial Intelligence in Women's Health Care	London (United Kingdom)	2021	11 - 50		NA	1 year ago
Juneau Biosciences	Juneau Biosciences is dedicated to advancing women's health through genetic research and testing, focusing on conditions like endometriosis.	Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis of all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in women’s health care. Research of other conditions is already underway. Over the next several years, Juneau will launch additional programs for preterm labor and other gynecological and obstetric disorders. Juneau expects to improve the lives of millions of women through our genetic research and innovative health care solutions. Juneau Biosciences’ knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities in order to commercialize these novel discoveries.	Genomic and Genetic Testing	Salt Lake City (United States)	2006	1 - 10	$7.91M	Venture - Series Unknown, $25.00K, December 4, 2013	1 year ago
UB UGenix Biotech	The company focuses on women's health through services like prenatal testing and offers genetic testing solutions, aligning well with the relevant requirements.	Developer and operator of a development and service platform designed for bio-gene technology and medical diagnosis. The company's platform includes clinical laboratory developed testing (LDT) items and equipment research and development platform, in vitro diagnostic (IVD) equipment, and detection kit research and development platform, the company's main services include prenatal testing, precision oncology, pathogen testing and other clinical testing, enabling medical users to improve genetic diagnostic performance and efficiency.	Genomic and Genetic Testing	Beijing (China)	2011	201 - 500		NA	1 year ago
LIFECONCEPT	Lifeconcept focuses on women's health by developing AI-powered wearable devices that monitor fertility and reproductive health.	At LIFECONCEPT Sp. z o.o. we combine medical knowledge, modern technologies and artificial intelligence - to effectively help people stay healthy and take care of themselves. Our goal is to develop innovative and practical solutions that will revolutionise thinking about preventive healthcare, being closer to users and their needs. Currently, we focus primarily on women's health and fertility, but we want to expand our portfolio to include products for people battling addictions, struggling with stress and obesity, and those suffering from chronic diseases. We are a startup with a mission and we work with a mission. Our team is made up of passionate roboticists, medical experts, engineers, designers and other professionals who enjoy what they do. Together we are pursuing a research and development project that will result in an innovative wearable device that monitors lifestyle, hormone levels and stress.	Artificial Intelligence in Women's Health Care	Olsztyn (Poland)	2021	11 - 50	$642.82K	Grant, $642.82K, October 1, 2021	1 year ago
Human Bytes	Human Bytes develops AI-driven solutions for digital mammography and women's health diagnostics, significantly improving patient outcomes.	Human Bytes will connect the Nordic healthcare with the worlds' leading artificial intelligence solutions, to improve patient outcome and health economics.	Artificial Intelligence in Women's Health Care	Hellerup (Denmark)	2021	11 - 50		NA	1 year ago
Matricis.ai	Matricis.ai focuses on advancing women's health through AI technologies, particularly in improving diagnostic accuracy for gynecological pathologies.	Matricis.ai brings the best science and cutting-edge machine learning algorithms to endometriosis research. We collaborate with radiologists to co-create medical-grade applications with the goal of improving diagnosis accuracy and democratizing the world's best specialists' expertise for all patients while saving time and reducing medical errancy.	Artificial Intelligence in Women's Health Care	Paris (France)	2022	1 - 10		Non-Equity Assistance, August 1, 2023	1 year ago

Cellula focuses on women's health through its engagement in reproductive health and offers advanced genetic testing solutions.

Researcher and developer of advanced genetic testing technology in the field of reproductive health. The company's technology focuses on the clinical application of cutting edge technologies in areas such as flow cytometry, and supporting reagents, non-invasive prenatal testing (NIPT), and tumor companion diagnosis through liquid biopsies, providing testing methods for various diseases.

Genomic and Genetic Testing

Series B, $7.32M, September 1, 2020

1 year ago

Genetic Technologies

Genetic Technologies is dedicated to advancing women's health through personalized risk assessments and comprehensive genetic testing solutions.

Genetic Technologies is a biotechnology research company. They offer medical diagnostic and sequencing services include medical, forensic, paternity and animal genomic testing, enabling physicians and doctors to get correct data for treatment of the patients.

Genomic and Genetic Testing

CognitiveCare is dedicated to advancing women's health through AI-driven risk detection and management solutions, particularly in maternal and infant health.

CognitiveCare is a trailblazing force in improving healthcare outcomes. We utilize scientific rigor to unveil and address health disparities, enhance disease prevention and management, accelerate health economics outcomes research, and catalyze optimal efficacy in pharma and life sciences. With a foundation rooted in patented and proprietary risk quantification and resource allocation algorithms, we serve payers, providers, policymakers, public health departments, pharma, and life sciences clients, driving impact for both individual and population health. CongitiveCare is poised to revolutionize the healthcare landscape through its algorithm hub, interdisciplinary approach, and real-world evidence expertise. The company's impactful strides in maternal and infant health, children's health, mental health, substance use disorder, eye health, infectious diseases, and pathology lay the foundation for accelerating our mission to build healthier communities.

Artificial Intelligence in Women's Health Care

Milpitas (United States)

2018

11 - 50

$300.00K

Seed, $300.00K, December 1, 2020

1 year ago

Prognica Labs

Prognica Labs is dedicated to advancing women's health through AI-driven technologies for early detection and diagnosis of breast cancer, including enhancements to mammography.

Prognica Labs is an AI based company working on early detection and diagnosis of breast cancer, with a strong mission to democratize early detection, diagnosis and treatment of Breast Cancer by making it more accurate, accessible & affordable. We have been at the forefront of bringing research, awareness, and economical and accessible screening solution to healthcare industry and the society.

Artificial Intelligence in Women's Health Care

Dubai (United Arab Emirates)

2019

1 - 10

Pre-Seed, July 16, 2019

1 year ago

Agnes Health

The company focuses on women's health and utilizes AI and telemedicine to improve health outcomes for women globally.

The Inclusive AI-Powered Health Ally for Women. On a mission to positively transform health indices for women, globally.

Artificial Intelligence in Women's Health Care

London (United Kingdom)

Juneau Biosciences is dedicated to advancing women's health through genetic research and testing, focusing on conditions like endometriosis.

Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis of all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in women’s health care. Research of other conditions is already underway. Over the next several years, Juneau will launch additional programs for preterm labor and other gynecological and obstetric disorders. Juneau expects to improve the lives of millions of women through our genetic research and innovative health care solutions. Juneau Biosciences’ knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities in order to commercialize these novel discoveries.

Genomic and Genetic Testing

Salt Lake City (United States)

2006

1 - 10

$7.91M

Venture - Series Unknown, $25.00K, December 4, 2013

1 year ago

UB

UGenix Biotech

The company focuses on women's health through services like prenatal testing and offers genetic testing solutions, aligning well with the relevant requirements.

Developer and operator of a development and service platform designed for bio-gene technology and medical diagnosis. The company's platform includes clinical laboratory developed testing (LDT) items and equipment research and development platform, in vitro diagnostic (IVD) equipment, and detection kit research and development platform, the company's main services include prenatal testing, precision oncology, pathogen testing and other clinical testing, enabling medical users to improve genetic diagnostic performance and efficiency.